Found 95 results
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
K. Gwinn, Odenkirchen, J., Krotoski, D., Sheikh, M., Ala'i, S., and Esterlitz, J., A Common Language for Clinical Research Studies: The National Institute of Neurological Disorders and Stroke (NINDS) Mitochondrial Disease Common Data Elements (CDE), in United Mitochondrial Disease Foundation Symposium, Herndon, VA, 2015.
C. Gurgol, Foley, A., Belt, P., Denzen, E., Duffy, S., Gallagher, C., Grodman, C., Horowitz, M., Confer, D., and Carter, S., Developing Materials for Transplant Centers to Share BMT CTN Clinical Trial Results with their Patients: A Pilot Study (Poster)., in NCI ASCO Cancer Trials Accrual Symposium, Bethesda, MD, 2010.
A. Guimarães-Walker, Mackie, N., McMichael, A., Weber, J., McCormack, S., Cebere, I., Kay, R., Hanke, T., Dally, L., Gibiansky, L., Legg, K., DeSouza, C., Hayes, P., Gilmour, J., and Fast, P., Priming with a Candidate HIV-1 Clade A DNA Vaccine Followed by Boosting with an HIV-1 Clade A MVA Vaccine in Volunteers at Low risk of HIV Infection, in AIDS Vaccine 2004 International Conference, Lausanne, Switzerland, 2004.
A. Guimarães-Walker, Mackie, N., McCormack, S., Hanke, T., Schmidt, C., Gilmour, J., Barin, B., McMichael, A., Weber, J., Legg, K., Babiker, A., Hayes, P., Gotch, F., Smith, C., Dally, L., Dorrell, L., Cebere, I., Kay, R., Winstone, N., Moore, S., Goonetilleke, N., and Fast, P., Lessons from IAVI-006, a Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of the PTHR.HIVA DNA and MVA.HIVA Vaccines in a Prime-Boost Strategy to Induce HIV-1 Specific T-Cell Responses in Healthy Volunteers, Vaccine, vol. 26, no. 51, pp. 6671-6677, 2008.
J. Gryczynski, McNeely, J., Wu, L. - T., Subramaniam, G. A., Svikis, D. S., Cathers, L. A., Sharma, G., King, J., Jelstrom, E., Nordeck, C. D., Sharma, A., Mitchell, S. G., O'Grady, K. E., and Schwartz, R. P., Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care, J Gen Intern Med, 2017.
AREDS Update I: The Effect of Cataract Surgery on Progression to Advanced AMD, in American Academy of Ophthalmology Meeting, Anaheim, CA, 2003.
A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss. Age-Related Eye Disease Study Report No. 8, Archives of Ophthalmology, vol. 119, no. 10, pp. 1417-1436, 2001.
The Age-Related Eye Disease Study: A Clinical Trial of Zinc and Antioxidants-Age-Related Eye Disease Study Report No. 2, J Nutrition, vol. 130, p. 1516S-19S, 2000.
L. Aiello, Davis, M., Girach, A., Kles, K., Milton, R., Sheetz, M., Vignati, L., and Zhi, X., Effect of Ruboxistaurin on Visual Loss in Patients With Diabetic Retinopathy, Ophthalmology, vol. 113, no. 12, pp. 2221-2230, 2006.
E. Chew, Clemons, T. E., SanGiovanni, J. P., Danis, R., Ferris, F. 3rd, Elman, M., Antoszyk, A., Ruby, A., Orth, D., Bressler, S., Fish, G., Hubbard, G., Klein, M., Chandra, S., ,, and Sperduto, R., Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression: AREDS 2 Report Number 3, JAMA Ophthalmol, vol. 132, no. 2, pp. 142-149, 2014.
National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS). AREDS Report No. 10, Arch Ophthalmol, vol. 121, pp. 211-217, 2003.
The Age-Related Eye Disease Study System for Classifying Age-Related Macular Degeneration from Stereoscopic Color Fundus Photographs: The Age-Related Eye Disease Study Report Number 6, Am J Ophthalmol, vol. 132, pp. 668-81, 2001.
Design Implications. AREDS Report No. 1, Control Clin Trials, vol. 20, no. 6, pp. 573-600, 1999.
The Effect of Ruboxistaurin on Visual Loss in Patients with Moderately Severe To Very Severe Nonproliferative Diabetic Retinopathy: Initial Results of The Protein Kinase C Beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) Clinical Trial, Diabetes, vol. 54, pp. 2188-2197, 2005.
AREDS Update II: Mortality and Nutritional Risk Factors, in American Academy of Ophthalmology Meeting, Anaheim, CA, 2003.
Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized Controlled Trial 1: Primary Outcomes, Pediatrics, vol. 105, pp. 295-310, 2000.
W. C. Chew, Clemons, T. E., Bressler, S. B., Elman, M. J., Danis, R. P., Domalpally, A., Heier, J. S., Kim, J. E., and Garfinkel, R., Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) Study, Ophthalmology, vol. 121, pp. 535-534, 2014.
The Age-Related Eye Disease Study (AREDS) System for Classifying Cataracts from Photographs: AREDS Report No. 4, Am J Ophthalmol, vol. 131, pp. 167-75, 2001.
Waiting List Mortality for Pediatric Patients with Chronic Liver Disease, 1998.
Risk Factors Associated with Age-Related Macular Degeneration. A Case-Control Study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study Report No. 3, Ophthalmology, vol. 107, pp. 2224-32, 2000.
AREDS Extension of the Wisconsin Age-Related Maculopathy Grading System, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 1997.
Impact of Antioxidants, Zinc, and Copper on Cognition in the Elderly. A Randomized, Controlled Trial. AREDS Report No. 12, Neurology, vol. 63, pp. 1705-1707, 2004.
E. Y. Chew, Clemons, T., SanGiovanni, J. P., Danis, R., Domalpally, A., McBee, W., Sperduto, R., and Ferris, F. L., The Age-Related Eye Disease Study 2 (AREDS2): Study Design and Baseline Characteristics (AREDS2 Report No. 1), Ophthalmology, vol. 119, pp. 2282-2289, 2012.
Baseline Nutritional Status of AREDS Participants, Poster Presentation by AREDS Participants, Experimental Biology, 1999.
Report from the Studies of Pediatric Liver Transplantation (SPLIT) Research Group, 1998.